These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25223483)

  • 1. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
    Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
    Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
    PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
    Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
    J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
    He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
    Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
    Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
    Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Du Y; Zhang YW; Pu R; Han X; Hu JP; Zhang HW; Wang HY; Cao GW
    Chin Med J (Engl); 2015 Apr; 128(8):1005-13. PubMed ID: 25881591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
    Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
    J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
    Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
    Song XM; Li QL; Guo F; Peng H; Guo JJ
    Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.
    Deng Y; Li P; Liu W; Pu R; Yang F; Song J; Yin J; Han X; Li C; Zhao J; Wang H; Cao G
    J Viral Hepat; 2020 Nov; 27(11):1150-1161. PubMed ID: 32568442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
    Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
    Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
    World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.